Thorp Clay

CIK 00015923804 companiesALPHARETTA, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001592380

Recent Transactions

50 trades

Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2025-02-24$0.92/sh+15,000→ 176,141 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2024-06-20+45,000→ 45,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2023-09-25$0.86/sh+10,000→ 40,522 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2023-06-22+30,000→ 30,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+3,750→ 36,693 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19+3,750→ 0 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-12-21$1.02/sh+14,000→ 30,522 total
Other
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-12-15+8,522→ 16,522 total
Other
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-12-15−1,406,507→ 3,545,040 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2022-06-22+30,000→ 30,000 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-05-17$2.97/sh+14,893→ 1,556,030 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-05-16$2.76/sh+21,802→ 1,541,137 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-03-28$7.20/sh+3,000→ 3,000 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-01-11$14.00/sh+265,000→ 1,519,335 total
Conversion
Vigil Neuroscience, Inc.
Series A Preferred Stock
2022-01-11−2,552,021→ 0 total
Conversion
Vigil Neuroscience, Inc.
Series B Preferred Stock
2022-01-11−926,506→ 0 total
Conversion
Vigil Neuroscience, Inc.
Common Stock
2022-01-11+1,254,335→ 1,254,335 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2021-08-18$3.00/sh+10,000→ 32,943 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-06-10+25,000→ 25,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-06-03+14,000→ 14,000 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-02-10$4.43/sh−32,873→ 3,433,521 total
Sale
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2021-02-10$4.43/sh−32,873→ 4,951,547 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-24$3.50/sh+2,000→ 22,943 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-23$3.67/sh+3,000→ 20,943 total
Other
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-16−52,397→ 0 total
Other
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-16+2,144→ 17,943 total
Other
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-16+10,586→ 15,432 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2020-06-18+25,000→ 25,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2020-06-03+16,000→ 16,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2019-11-22$1.05/sh+1,518,026→ 4,984,420 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-07-01$14.00/sh−459→ 415,959 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-07-01$14.00/sh−180→ 162,890 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-07-01$14.00/sh−2,014→ 1,818,638 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-07-01$14.00/sh−255→ 52,397 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2019-06-20+20,000→ 20,000 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-06-18$14.00/sh−277→ 1,820,656 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-06-18$14.00/sh−35→ 52,655 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-06-18$14.00/sh−63→ 416,418 total
Sale
PhaseBio Pharmaceuticals Inc
Common Stock
2019-06-18$14.00/sh−25→ 163,074 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2019-05-09+11,000→ 11,000 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-02-27+36,000→ 36,000 total
Purchase
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2018-12-06$1.36/sh+8,000→ 8,000 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-12-04$3.13/sh+4,000→ 15,799 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+52,690→ 52,690 total
Conversion
PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
2018-10-22−42,530→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−41,414→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−226,061→ 0 total
Sale
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$5.00/sh−104→ 13,558 total

Companies

Recent Filings

Address

C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200

ALPHARETTA, GA, 30005

View on SEC.gov